Prevention of recurrent preterm delivery by 17 alpha–hydroxyprogesterone caproate

Cited by (1,000)

Items 501–600 of 1,000

1. Regulation of the human relaxin genes H1 and H2 by steroid hormones
   Jermelina L Garibay-Tupas, Kristie J Okazaki, LILY TASHIMA, Sandra Y. Yamamoto, Gillian D. Bryant‐Greenwood · 2004 · Molecular and Cellular Endocrinology
2. Does midtrimester cervical length ≥25 mm predict preterm birth in high-risk women?
   John Owen, Jeff M. Szychowski, Gary Hankins, Jay D. Iams, Jeanne S. Sheffield, Annette Perez‐Delboy, Vincenzo Berghella, Deborah A. Wing, Edwin R. Guzman · 2010 · American Journal of Obstetrics and Gynecology
3. Medical cost savings associated with 17 alpha-hydroxyprogesterone caproate
   Jennifer L. Bailit, Mark Edward Votruba · 2007 · American Journal of Obstetrics and Gynecology
4. Admixture Mapping to Identify Spontaneous Preterm Birth Susceptibility Loci in African Americans
   Tracy Ann Manuck, Yinglei Lai, Paul J. Meis, Baha M. Sibai, Catherine Y. Spong, Dwight J. Rouse, Jay D. Iams, Steve N. Caritis, Mary J. O’Sullivan, Ronald J. Wapner et al. · 2011 · Obstetrics and Gynecology
5. Prematurity prevention: the role of progesterone
   Eduardo Borges da Fonseca, Roberto Eduardo Bittar, Rievani de Sousa Damião, Marcelo Zugaib · 2009 · Current Opinion in Obstetrics & Gynecology
6. Biology of Parturition
   Errol R. Norwitz, Stephen James Lye · 2009 · Elsevier eBooks
7. Progestogens for Maintenance Tocolysis in Women With a Short Cervix
   Fabio Facchinetti, Patrizia Vergani, Mariarosaria Di Tommaso, Luca Marozio, Barbara Acaia, Roberto Vicini, Lucrezia Pignatti, Anna Locatelli, Marina Spitaleri, Chiara Benedetto et al. · 2017 · Obstetrics and Gynecology
8. Prevention of Prematurity
   Balaji Govindaswami, Priya Jegatheesan, Matthew J. R. Nudelman, Sudha Rani Narasimhan · 2018 · Clinics in Perinatology
9. Progesterone for the Prevention of Preterm Birth – an Update of Evidence-Based Indications
   Ruben‐J. Kuon, Pauline Voß, Werner H. Rath · 2019 · Geburtshilfe und Frauenheilkunde
10. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/025, September 2022) – Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth
    Richard E. Berger, Harald Abele, Franz Bahlmann, Klaus J. Doubek, Ursula Felderhoff‐Müser, Herbert Fluhr, Yves Garnier, Susanne Grylka‐Baeschlin, Aurelia Hayward, Hanns Helmer et al. · 2023 · Geburtshilfe und Frauenheilkunde
11. First‐trimester prediction of preterm birth using ADAM12, PAPP‐A, uterine artery Doppler, and maternal characteristics
    Katherine R. Goetzinger, Alison G. Cahill, Janet Kemna, Linda Odibo, George A. Macones, Anthony O. Odibo · 2012 · Prenatal Diagnosis
12. Metabolism of 17α-hydroxyprogesterone caproate by hepatic and placental microsomes of human and baboons
    Ru Yan, Tatiana N. Nanovskaya, Olga L. Zharikova, Donald R. Mattison, Gary D.V. Hankins, Mahmoud S. Ahmed · 2008 · Biochemical Pharmacology
13. Behavioral Influences on Preterm Birth: Integrated Analysis of the Pregnancy, Infection, and Nutrition Study
    David A. Savitz, Quaker E. Harmon, Anna Maria Siega‐Riz, Amy H. Herring, Nancy Dole, John M. Thorp · 2011 · Maternal and Child Health Journal
14. The utility of fetal fibronectin in the prediction and prevention of spontaneous preterm birth.
    Daniel G. Kiefer, Anthony Mark Vintzileos · 2008 · PubMed Central
15. Hospitalization for Women With Arrested Preterm Labor
    Nicole P. Yost, Steven L. Bloom, Donald D. McIntire, Kenneth J. Leveno · 2005 · Obstetrics and Gynecology
16. Universal cervical length screening for preterm birth prevention in the United States*
    Adeeb Khalifeh, Johanna Quist‐Nelson, Vincenzo Berghella · 2016 · The Journal of Maternal-Fetal & Neonatal Medicine
17. Prevention of preterm delivery with 17-hydroxyprogesterone caproate: Pharmacologic considerations
    Maisa N. Feghali, Raman Venkataramanan, Steve N. Caritis · 2014 · Seminars in Perinatology
18. Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate
    Jeff M. Szychowski, Vincenzo Berghella, John Owen, Gary Hankins, Jay D. Iams, Jeanne S. Sheffield, Annette Perez‐Delboy, Deborah A. Wing, Edwin R. Guzman, for the Vaginal Ultrasound Trial Consortium · 2012 · The Journal of Maternal-Fetal & Neonatal Medicine
19. Addition of adjuvant progesterone to physical‐exam‐indicated cervical cerclage to prevent preterm birth
    Eun Young Jung, Kyung Joon Oh, Joon‐Seok Hong, Bo Ryoung Han, Jung Kyung Joo · 2016 · Journal of obstetrics and gynaecology research
20. A systematic review and meta‐analysis of randomized controlled trials comparing 17‐alpha‐hydroxyprogesterone caproate versus placebo for the prevention of recurrent preterm birth
    Rosa Fernández-Macías, Raigam Jafet Martinez-Portilla, Lucas Cerrillos, F. Figueras, Montse Palacio · 2019 · International Journal of Gynecology & Obstetrics
21. Protease inhibitor-based antiretroviral therapy in pregnancy: effects on hormones, placenta, and decidua
    Caroline Dunk, Lena Serghides · 2021 · The Lancet HIV
22. Follow-up cervical length in asymptomatic high-risk women and the risk of spontaneous preterm birth
    J. M. G. Crane, Donna Hutchens · 2010 · Journal of Perinatology
23. Setting up a preterm prevention clinic: a practical guide
    Ronnie Lamont · 2006 · BJOG An International Journal of Obstetrics & Gynaecology
24. The effect of omega-3 supplementation on pregnancy outcomes by smoking status
    Spencer G. Kuper, Adi Abramovici, Victoria Chapman Jauk, Lorie M. Harper, Joseph Biggio, Alan Tita · 2017 · American Journal of Obstetrics and Gynecology
25. The Endocrinology of Human Pregnancy and Fetoplacental Neuroendocrine Development
    Sam A. Mesiano · 2009 · Elsevier eBooks
26. 17α-hydroxyprogesterone Caproate for the Prevention of Preterm Delivery
    Anthony O. Odibo, David M. Stamilio, George A. Macones, Daniel E. Polsky · 2006 · Obstetrics and Gynecology
27. Ultrasound Measurement of the Fetal Adrenal Gland as a Predictor of Spontaneous Preterm Birth
    Matthew Hoffman, Ozhan Mehmet Turan, Corette B. Parker, Ronald J. Wapner, Deborah A. Wing, David M. Haas, Michael Sean Esplin, Samuel I. Parry, William A. Grobman, Hyagriv N. Simhan et al. · 2016 · Obstetrics and Gynecology
28. PREMATURITY AND POTENTIAL PREDICTORS
    Tiffany Martini Field, Miguel Diego, Maria Hernandez‐Reif · 2008 · International Journal of Neuroscience
29. Bridging progestogens in pregnancy and pregnancy prevention
    Elizabeth Micks, Greta B. Raglan, Jay A. Schulkin · 2015 · Endocrine Connections
30. Progestogens for treatment and prevention of pregnancy disorders
    Adolf Eduard Schindler · 2010 · Hormone Molecular Biology and Clinical Investigation
31. Disparities and relative risk ratio of preterm birth in six Central and Eastern European centers
    Chander Arora, Marián Kacerovský, Balázs Zinner, Tibor Ertl, Iuliana Ceauşu, Igor Rusňák, S.О. Shurpyak, Meenu Sandhu, Calvin J. Hobel, Daniel Anthony Dumesic et al. · 2015 · Croatian Medical Journal
32. Progestogens as Maintenance Treatment in Arrested Preterm Labor
    Montse Palacio, Stefania Ronzoni, Luis Sanchez‐Ramos, Kellie E. Murphy · 2016 · Obstetrics and Gynecology
33. The selective progesterone receptor modulator-promegestone-delays term parturition and prevents systemic inflammation-mediated preterm birth in mice
    Oksana P. Shynlova, Lubna Nadeem, Anna Dorogin, Sam A. Mesiano, Stephen James Lye · 2021 · American Journal of Obstetrics and Gynecology
34. The association between maternal anemia during pregnancy and preterm birth
    Rozhan Khezri, Shaker Salarilak, Sepideh Jahanian · 2023 · Clinical Nutrition ESPEN
35. Randomized controlled trials: not always the “gold standard” for evidence in obstetrics and gynecology
    Yinka Oyelese · 2023 · American Journal of Obstetrics and Gynecology
36. Trial protocol OPPTIMUM– Does progesterone prophylaxis for the prevention of preterm labour improve outcome?
    Jane Elizabeth Norman, Andrew H. Shennan, Phillip R. Bennett, Steven Thornton, Stephen Courtenay Robson, Neil Marlow, John D. Norrie, Stavros Petrou, Neil James Sebire, Tina Lavender et al. · 2012 · BMC Pregnancy and Childbirth
37. Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome (PROGRESS): a randomised controlled trial
    Jodie M Dodd, Caroline Anne Crowther, Andrew J McPhee, Vicki Flenady, Jeffrey Samuel Robinson · 2009 · BMC Pregnancy and Childbirth
38. Vaginal progesterone as maintenance treatment after an episode of preterm labour ( PROMISE ) study: a multicentre, double‐blind, randomised, placebo‐controlled trial
    Montse Palacio, Teresa Cobo, Eugenia Antolin, Maria E. Ramirez, F Cabrera, F Mozo de Rosales, J. L. Bartha, M. Juan, A Martí, Daniel Oros et al. · 2016 · BJOG An International Journal of Obstetrics & Gynaecology
39. Early mid-trimester serum relaxin, soluble CD163, and cervical length in women at high risk for preterm delivery
    Ida Vogel, Alice R. Goepfert, Holger Jon Møller, Suzanne Cliver, Poul Thorsen, William W. Andrews · 2006 · American Journal of Obstetrics and Gynecology
40. Les membranes fœtales : développement embryologique, structure et physiopathologie de la rupture prématurée avant terme
    Jean‐Charles Pasquier, Muriel Doret · 2008 · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction
41. Recurrent second trimester pregnancy loss: evaluation and management
    Stephanie E. Dukhovny, Priyanka Zutshi, Jodi F. Abbott · 2009 · Current Opinion in Endocrinology Diabetes and Obesity
42. Unjustified Increase in Cost of Care Resulting From U.S. Food and Drug Administration Approval of Makena (17α-Hydroxyprogesterone Caproate)
    Arnold W. Cohen, Joshua A. Copel, George A. Macones, M. Kathryn Menard, Laura Riley, George Robert Saade · 2011 · Obstetrics and Gynecology
43. The birth weight in pregnant women with Asherman syndrome compared to normal intrauterine cavity
    Saeed Baradwan, Afnan Baradwan, Muhammed Salman Bashir, Dania Al‐Jaroudi · 2018 · Medicine
44. Cost-Effectiveness of a Proteomic Test for Preterm Birth Prediction
    Michael Grabner, Julja Burchard, Chi Nguyen, Haechung Chung, Nilesh Gangan, J. Jay Boniface, John A. F. Zupancic, Eric J. Stanek · 2021 · ClinicoEconomics and Outcomes Research
45. Low-dose aspirin for the prevention of preterm birth: More questions than answers
    Victoria Hodgetts Morton, Sarah Jane Stock · 2022 · PLoS Medicine
46. Vaginal progesterone compared with intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in singleton gestations: a systematic review and meta-analysis
    Rupsa C. Boelig, Mariavittoria Locci, Gabriele Saccone, Elisabetta Gragnano, Vincenzo Berghella · 2022 · American Journal of Obstetrics & Gynecology MFM
47. Alternative pathway activation in pregnancy, a measured amount “complements” a successful pregnancy, too much results in adverse events
    Kate Smith‐Jackson, Richard A. Harrison · 2022 · Immunological Reviews
48. FIGO Good Practice Recommendations on the use of progesterone in the management of recurrent first‐trimester miscarriage
    Hassan A. Shehata, Abdullatif Elfituri, Stergios K. Doumouchtsis, Mudiaga Eseajeberuo Zini, Amanda Ali, Haider Jan, Ramesh Ganapathy, Hema Divakar, Moshe Hod · 2023 · International Journal of Gynecology & Obstetrics
49. Role of Vascular Endothelial Growth Factor in Maintenance of Pregnancy in Mice
    Yoshiko Wada, Hiromi Ozaki, Naomichi Abe, Asami Mori, Kenji Sakamoto, Tohru Nagamitsu, Tsutomu Nakahara, Kunio Ishii · 2013 · Endocrinology
50. Matched sample comparison of intramuscular versus vaginal micronized progesterone for prevention of preterm birth
    Mohamed Nabih EL-Gharib, T.M. Elhawary · 2012 · The Journal of Maternal-Fetal & Neonatal Medicine · Retracted
51. Preterm labour and prematurity
    Penny C. McParland, Griff Jones, David Taylor · 2004 · Current Obstetrics and Gynaecology
52. A Preconception Nomogram to Predict Preterm Delivery
    Shilpi S. Mehta‐Lee, Anton M. Palma, Peter Samuel Bernstein, David William Lounsbury, Nicolas F. Schlecht · 2016 · Maternal and Child Health Journal
53. Women with Symptomatic Preterm Birth Have a Distinct Cervicovaginal Metabolome
    Laura M. Anglim, Julie Romero, Amy G. Brown, Michal A. Elovitz, Jeny P. Ghartey · 2017 · American Journal of Perinatology
54. Progesterone improves perinatal neuromotor outcomes in a mouse model of intrauterine inflammation via immunomodulation of the placenta
    Christopher M. Novak, Maide Özen, Michael McLane, Sadiq Alqutub, Ji Yeon Lee, Jun Lei, Irina D. Burd · 2018 · American Journal of Reproductive Immunology
55. The Role Of Progestogens In Threatened And Idiopathic Recurrent Miscarriage
    Hisham Arab, Ahmed Jaber Alharbi, Ayman Oraif, Emad R. Sagr, Hana Al Madani, Hassan S. Abduljabbar, Osama Sadeak Bajouh, Yaser A. Faden, Yasser Sabr · 2019 · International Journal of Women s Health
56. Gestational age of previous twin preterm birth as a predictor for subsequent singleton preterm birth
    Timothy J. Rafael, Matthew Hoffman, Benjamin E. Leiby, Vincenzo Berghella · 2011 · American Journal of Obstetrics and Gynecology
57. Recurrent Risk of Adverse Pregnancy Outcome
    Lisa E. Moore · 2008 · Obstetrics and Gynecology Clinics of North America
58. Progesterone, Inflammatory Cytokine (TNF-α), and Oxidative Stress (H2O2) Regulate Progesterone Receptor Membrane Component I Expression in Fetal Membrane Cells
    Yan Meng, Amy P Murtha, Liping Feng · 2016 · Reproductive Sciences
59. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition
    Errol R. Norwitz, Victoria Snegovskikh, Frederick Schatz, Nastaran Foyouzi, Md Mizanur Rahman, Lynn F. Buchwalder, Hee Joong Lee, Edmund F. Funai, Catalin Sorin Buhimschi, Irina Alexandra Buhimschi et al. · 2007 · American Journal of Obstetrics and Gynecology
60. Progestational agents for treating threatened or established preterm labour
    Linlin Su, Miny Samuel, Yap Seng Chong · 2010 · Cochrane Database of Systematic Reviews
61. The promise and pitfalls of precision medicine to resolve black–white racial disparities in preterm birth
    Heather H. Burris, Clyde J. Wright, Haresh Murli Kirpalani, James W. Collins, Scott A. Lorch, Michal A. Elovitz, Sunah Susan Hwang · 2019 · Pediatric Research
62. Progesterone alters human cervical epithelial and stromal cell transition and migration: Implications in cervical remodeling during pregnancy and parturition
    Ourlad Alzeus G. Tantengco, Lauren Richardson, Joy Vink, Talar B. Kechichian, Paul Mark B. Medina, Richard B. Pyles, Ramkumar Menon · 2021 · Molecular and Cellular Endocrinology
63. Perinatal care for the extremely preterm infant
    Haruo Usuda, Sean William David Carter, Tsukasa Takahashi, John P. Newnham, Erin L. Fee, Alan Hall Jobe, Matthew W. Kemp · 2022 · Seminars in Fetal and Neonatal Medicine
64. Society for Maternal-Fetal Medicine Statement: Response to the Food and Drug Administration’s withdrawal of 17-alpha hydroxyprogesterone caproate
    2023 · American Journal of Obstetrics and Gynecology
65. Maternal Age and Preterm Births in Singleton and Twin Pregnancies Conceived By In Vitro Fertilisation in the U nited S tates
    Xu Xiong, Richard Palmer Dickey, Gabriella C. Pridjian, Pierre M Buekens · 2014 · Paediatric and Perinatal Epidemiology
66. Does the clinical presentation of a prior preterm birth predict risk in a subsequent pregnancy?
    Daphnie Drassinower, Sarah Gloria Običan, Zainab Siddiq, Danielle R. Heller, Cynthia Gyamfi‐Bannerman, Alexander Michael Friedman · 2015 · American Journal of Obstetrics and Gynecology
67. Effect of 17‐alpha hydroxyprogesterone caproate on cervical length in twin pregnancies
    Arianne Lim, Ewoud Schuit, Dimitri N.M. Papatsonis, Jim van Eyck, MARTINA M. PORATH, Charlotte M van Oirschot, Piet Hummel, Tom H.M. Hasaart, Gunilla Kleiverda, Irene M. de Graaf et al. · 2012 · Ultrasound in Obstetrics and Gynecology
68. Negative Effects of Progesterone Receptor Isoform-A on Human Placental Activity of the Noncanonical NF-κB Signaling
    Bingbing Wang, Nataliya Parobchak, Max Rosen, Natalie Roche, Todd Rosen · 2013 · The Journal of Clinical Endocrinology & Metabolism
69. 17α-Hydroxyprogesterone Caproate Access in the Louisiana Medicaid Population
    Mary Kathryn Orsulak, Dana Block‐Abraham, Rebekah Elizabeth Gee · 2015 · Clinical Therapeutics
70. Goals and Strategies for Prevention of Preterm Birth: An Obstetric Perspective
    Christopher Lang, Jay D. Iams · 2009 · Pediatric Clinics of North America
71. Single dose 17 alpha-hydroxyprogesterone caproate in preterm labor: a randomized trial
    Peng Chiong Tan, Anthonia Siaw Jia King, Narayanan Vallikkannu, Siti Zawiah Omar · 2011 · Archives of Gynecology and Obstetrics
72. The Role of Progesterone and a Novel Progesterone Receptor, Progesterone Receptor Membrane Component 1, in the Inflammatory Response of Fetal Membranes to Ureaplasma parvum Infection
    Liping Feng, Carla E. Ransom, Matthew N. Nazzal, Terrence K. Allen, Yi‐Ju Li, Tracy Truong, Lauren C. Potts, Patrick Casey Seed, Amy P Murtha · 2016 · PLoS ONE
73. Progestin therapy to prevent preterm birth: History and effectiveness of current strategies and development of novel approaches
    Sam A. Mesiano, Gregory A. Peters, Peyvand Amini, Rachel A. Wilson, Gregory P. Tochtrop, Focco van den Akker · 2019 · Placenta
74. Cytokine profiling: variation in immune modulation with preterm birth vs. uncomplicated term birth identifies pivotal signals in pathogenesis of preterm birth
    Jeffrey M. Denney, Edward L. Nelson, Pathick Wadhwa, Thaddeus P. Waters, Leny Mathew, Robert L. Goldenberg, Jennifer Flatow Culhane · 2020 · Journal of Perinatal Medicine
75. Prophylactic oral betamimetics for preventing preterm labour in singleton pregnancies
    Melissa K. Whitworth, Siobhan M. Quenby · 2008 · Cochrane Database of Systematic Reviews
76. Differing In Vitro Potencies of Tocolytics and Progesterone in Myometrium From Singleton and Twin Pregnancies
    Sarah Arrowsmith, James P Neilson, Leanne Bricker, Susan Wray · 2015 · Reproductive Sciences
77. Lessons learned from the Philadelphia Collaborative Preterm Prevention Project: the prevalence of risk factors and program participation rates among women in the intervention group
    David A. Webb, Leny Mathew, Jennifer Flatow Culhane · 2014 · BMC Pregnancy and Childbirth
78. 17 Progesterone for preterm birth prevention: a potential $2 billion opportunity
    Joanne Armstrong · 2007 · American Journal of Obstetrics and Gynecology
79. Prior Ultrasound-Indicated Cerclage
    Anju Suhag, Laura Sanapo, Sushma Potti, Vincenzo Berghella · 2014 · Obstetrics and Gynecology
80. Experimental drugs for the inhibition of preterm labor
    Tegan Triggs, Sailesh Kumar, Murray David Mitchell · 2020 · Expert Opinion on Investigational Drugs
81. Progesterone Modulates Integrin α2 (ITGA2) and α11 (ITGA11) in the Pregnant Cervix
    Huiling Ji, Vit Long, Victoria Briody, Edward K. Chien · 2010 · Reproductive Sciences
82. Influence of gestational age and reason for prior preterm birth on rates of recurrent preterm delivery
    Víctor Hugo González-Quintero, Yvette C. Cordova, Niki B. Istwan, Felipe Jose Tudela, Debbie Rhea, Letty Romary, Adrian Marimon, Cheryl N. Desch, Gary J. Stanziano · 2011 · American Journal of Obstetrics and Gynecology
83. Recent Progress in Therapeutics for Inflammation-Associated Preterm Birth: A Review
    Ayumi Taguchi, Aki Yamashita, Kei Kawana, Takeshi Nagamatsu, Hitomi Furuya, Inoue Eri, Yutaka Osuga, Tomoyuki Fujii · 2015 · Reproductive Sciences
84. Preterm Labor and Birth
    Hyagriv N. Simhan, Jay D. Iams, Roberto J. Romero · 2017 · Elsevier eBooks
85. “Natural” progesterone: information on fetal effects
    Mari S. Golub, Farla L. Kaufman, Marlissa A. Campbell, Leping Li, James M. Donald · 2006 · Birth Defects Research Part B Developmental and Reproductive Toxicology
86. Cervical Cerclage for the Prevention of Preterm Birth
    John Owen, Melissa Mancuso · 2012 · Obstetrics and Gynecology Clinics of North America
87. Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy
    Waralak Yamasmit, Surasith Chaithongwongwatthana, Jorge E. Tolosa, Sompop Limpongsanurak, Leonardo Madeira Pereira, Pisake Lumbiganon · 2012 · Cochrane Database of Systematic Reviews
88. Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial
    Joan T. Price, Bellington Vwalika, Bethany L. Freeman, Stephen R. Cole, Helen B. Mulenga, Jennifer Winston, Felistas Mbewe, Elwyn Chomba, LYNNE M. MOFENSON, Dwight J. Rouse et al. · 2019 · BMC Pregnancy and Childbirth
89. Current Preterm Birth Prevention Strategies
    Noelle Breslin, Cynthia Gyamfi‐Bannerman · 2020 · Clinics in Perinatology
90. Placental transfer and vascular effects of pharmaceutical drugs in the human placenta ex vivo: A review
    Hedwig van Hove, Line Mathiesen, Jolien J. M. Freriksen, Kirsi Vähäkangas, Angela P. H. Colbers, Paul Brownbill, Rick Greupink · 2022 · Placenta
91. Progesterone and its receptor signaling in cervical remodeling: Mechanisms of physiological actions and therapeutic implications
    Sudeshna Tripathy, Shanmugasundaram Nallasamy, Mala Mahendroo · 2022 · The Journal of Steroid Biochemistry and Molecular Biology
92. Pathological interactions with the timing of birth and uterine activation
    Roger Smith, Dirk F Van Helden, Jonathan J. Hirst, Tamás Zakár, Mark READ, Eng‐Cheng Chan, Hannah K. Palliser, Dimitris K Grammatopoulos, Richard C. Nicholson, Helena C. Parkington · 2007 · Australian and New Zealand Journal of Obstetrics and Gynaecology
93. Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection
    John L. Chollet, Michael J. Jozwiakowski · 2012 · Drug Development and Industrial Pharmacy
94. The prediction of recurrent preterm birth in patients on 17-alpha-hydroxyprogesterone caproate using serial fetal fibronectin and cervical length
    Julie Romero, Andrei Rebarber, Daniel H. Saltzman, Rachel M. Schwartz, Danielle A. Peress, Nathan S. Fox · 2012 · American Journal of Obstetrics and Gynecology
95. Hydroxyprogesterone caproate injection (makena) one year later: to compound or not to compound that is the question.
    Yesha Patel, Martha M. Rumore · 2012 · Europe PMC (PubMed Central)
96. Abnormal Progesterone and Corticotropin Releasing Hormone Levels are Associated with Preterm Labour
    Foteini Stamatelou, Efthimios Deligeoroglou, Georgios Farmakides, Georgios Creatsas · 2009 · Annals of the Academy of Medicine Singapore
97. Patient characteristics associated with 17-alpha hydroxyprogesterone caproate use among a high-risk cohort
    Amy L. Turitz, Jamie A. Bastek, Stephanie Erin Purisch, Michal A. Elovitz, Lisa Danielle Levine · 2015 · American Journal of Obstetrics and Gynecology
98. The study of progesterone action in human myometrial explants
    Ektoras X Georgiou, Kaiyu Lei, Pei F. Lai, Angela Yulia, Bronwen R. Herbert, M. Castellanos, Sean Tobias May, Suren Rao Sooranna, Mark Richard Johnson · 2016 · Molecular Human Reproduction
99. Outcomes With Cerclage Alone Compared With Cerclage Plus 17α-Hydroxyprogesterone Caproate
    Bethany T. Stetson, Judith U. Hibbard, Isabelle A. Wilkins, Heidi Kay Leftwich · 2016 · Obstetrics and Gynecology
100. 17α-Hydroxyprogesterone Caproate and the Risk of Glucose Intolerance in Pregnancy
     Ahizechukwu Chigoziem Eke, Jeanne S. Sheffield, Ernest M. Graham · 2019 · Obstetrics and Gynecology